Vicus Capital Zoetis Inc. Transaction History

Vicus Capital

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$145.54 - $178.83 $38,568 - $47,389	265 Added 15.04%	2,027 $351,000
Q1 2024 Apr 17, 2024	BUY	$165.67 - $199.94 $291,910 - $352,294	1,762 New	1,762 $298,000
Q3 2023 Oct 23, 2023	BUY	$167.14 - $192.77 $297,342 - $342,937	1,779 New	1,779 $309,000
Q2 2021 Aug 10, 2021	SELL	$155.9 - $187.99 $292,312 - $352,481	-1,875 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$144.0 - $169.39 $19,296 - $22,698	134 Added 7.7%	1,875 $295,000
Q4 2020 Feb 01, 2021	BUY	$157.07 - $174.35 $17,591 - $19,527	112 Added 6.88%	1,741 $288,000
Q3 2020 Nov 12, 2020	SELL	$137.1 - $165.37 $1,371 - $1,653	-10 Reduced 0.61%	1,629 $269,000
Q2 2020 Aug 03, 2020	BUY	$111.92 - $142.53 $183,436 - $233,606	1,639 New	1,639 $225,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

Stay updated on Vicus Capital with notifications on news.